The U.S. Food and Drug Administration has given the nod to Abilify MyCite, for use in patients with schizophrenia, an add-on treatment for depression, and to help control episodes of either manic or "mixed" episodes for people with bipolar disorder.
From: https://www.webmd.com/a-to-z-guides/news/20171114/digital-pill-lets-doctors-know-its-been-taken?src=RSS_PUBLIC
No comments:
Post a Comment